Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00998036
Recruitment Status : Completed
First Posted : October 20, 2009
Last Update Posted : December 13, 2017
Wyeth is now a wholly owned subsidiary of Pfizer
Genentech, Inc.
Information provided by (Responsible Party):
Kevin Kalinsky, Columbia University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : October 2012